COVER.METALNATION.ORG
BY VASANTHA
COVER.METALNATION.ORG
Multiple RSV vaccines are expected to be approved by the FDA this year. Shots for infants are in development, but they are aimed at older adults.
COVER.METALNATION.ORG
Food and Drug Administration is poised to approve several respiratory syncytial virus vaccines by next winter, roughly six decades after the first attempt.
COVER.METALNATION.ORG
In the United States, there has never been an approved RSV vaccine. There are two vaccine applications under review by the FDA - one from Pfizer and one from GlaxoSmithKline.
COVER.METALNATION.ORG
Monoclonal antibodies are close behind to protect babies. It serves the same purpose as a vaccine. AstraZeneca and Sanofi have already approved the shot in Europe, and the FDA is reviewing their application.
COVER.METALNATION.ORG
RSV is often contracted multiple times throughout life and infects most people by age 2. Approximately 300 children under 5 die annually from this virus in the U.S.
COVER.METALNATION.ORG
Children's hospitals were overwhelmed by RSV cases earlier this winter, reminding us of the virus's danger. Pharmaceutical companies have been racing to market vaccines since then.
THANKS FOR READING
TO KNOW ABOUT Kevin O'Leary tears up while buying Swiss watch in Shark Tank CLICK HERE TO EXPLORE
COVER.METALNATION.ORG